Interdomain engineered disulfide bond permitting elucidation of mechanisms of inactivation of coagulation factor Va by activated protein C
Open Access
- 1 September 2002
- journal article
- Published by Wiley in Protein Science
- Vol. 11 (9), 2091-2101
- https://doi.org/10.1110/ps.0210002
Abstract
Procoagulant factor Va (FVa) is inactivated via limited proteolysis at three Arg residues in the A2 domain by the anticoagulant serine protease, activated protein C (APC). Cleavage by APC at Arg306 in FVa causes dissociation of the A2 domain from the heterotrimeric A1:A2:A3 structure and complete loss of procoagulant activity. To help distinguish inactivation mechanisms involving A2 domain dissociation from inactivation mechanisms involving unfavorable changes in factor Xa (FXa) affinity, we used our FVa homology model to engineer recombinant FVa mutants containing an interdomain disulfide bond (Cys609‐Cys1691) between the A2 and A3 domains (A2‐SS‐A3 mutants) in addition to cleavage site mutations, Arg506Gln and Arg679Gln. SDS‐PAGE analysis showed that the disulfide bond in A2‐SS‐A3 mutants prevented dissociation of the A2 domain. In the absence of A2 domain dissociation from the A1:A2:A3 trimer, APC cleavage at Arg306 alone caused a sevenfold decrease in affinity for FXa, whereas APC cleavages at Arg306, Arg506, and Arg679 caused a 70‐fold decrease in affinity for FXa and a 10‐fold decrease in the kcat of the prothrombinase complex for prothrombin without any effect on the apparent Km for prothrombin. Therefore, for FVa inactivation by APC, dissociation of the A2 domain may provide only a modest final step, whereas the critical events are the cleavages at Arg506 and Arg306, which effectively inactivate FVa before A2 dissociation can take place. Nonetheless, for FVa Leiden (Gln506‐FVa) inactivation by APC, A2 domain dissociation may become mechanistically important, depending on the ambient FXa concentration.Keywords
This publication has 55 references indexed in Scilit:
- A Model Describing the Inactivation of Factor Va by APC: Bond Cleavage, Fragment Dissociation, and Product InhibitionBiochemistry, 1999
- Binding Site for Blood Coagulation Factor Xa Involving Residues 311–325 in Factor VaJournal of Biological Chemistry, 1998
- Human Factor Va1 and Factor Va2: Properties in the Procoagulant and Anticoagulant PathwaysBiochemistry, 1997
- Peptide Bond Cleavages and Loss of Functional Activity during Inactivation of Factor Va and Factor VaR506Q by Activated Protein CPublished by Elsevier ,1995
- A visual protein crystallographic software system for X11/XviewJournal of Molecular Graphics, 1992
- The coagulation cascade: initiation, maintenance, and regulationBiochemistry, 1991
- MOLSCRIPT: a program to produce both detailed and schematic plots of protein structuresJournal of Applied Crystallography, 1991
- Stereochemical modeling of disulfide bridges. Criteria for introduction into proteins by site-directed mutagenesisProtein Engineering, Design and Selection, 1989
- Computer-aided model-building strategies for protein designBiochemistry, 1986
- Directed Mutagenesis of Dihydrofolate ReductaseScience, 1983